Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity, and yielded novel insights into tumor evolution, therapeutic response & resistance, and measurable residual disease (MRD). Mission Bio's Tapestri Platform enables the co-detection of SNVs, CNVs, and immunophenotypes from the same cell with a single, high-throughput workflow.